Optimised method could facilitate analysis of complex biologics
25 January 2024
An effective analytical framework for a broad spectrum of monoclonal antibodies (mAbs) and complex mAb biotherapeutics has been developed, according to a recent study.
Could novel antibiotic successfully treat a ‘priority 1 pathogen’?
25 January 2024
Highlighting the potential of a novel antibiotic against acinetobacter infections, GlobalData explained that nine other drugs, alongside this promising treatment, are in clinical development for this indication.
Will new therapeutic agent replace antibodies for bacterial detection?
24 January 2024
Aptamers offer a “cutting-edge approach” for identifying gram-negative bacterial pathogens, a paper suggests. As a tool for detecting and identifying bacteria, aptamers are a promising new class of synthetic nucleic acid molecules that can be used to detect and treat of pathogenic bacteria.
Cognito deepens analysis of neuromod device for Alzheimer’s with launch of biomarker substudy
24 January 2024
During the 12-month Hope study, participants will undergo a series of assessments to determine whether Cognito's technology helps to slow or stop the progression of Alzheimer's. The newly launched biomarker substudy, meanwhile, will add in evaluations of certain MRI, cerebrospinal fluid and plasma biomarkers.
Researchers link immune dysfunction to long COVID, opening door to new treatments
23 January 2024
Hours after U.S. Congress members heard pleas from patients and clinicians clamoring for research funding into long COVID, scientists from the University of Zurich released a new study that could explain the mechanism behind the condition—a step towards developing new treatments.
Russian authorities are negotiating with India to build a pharmaceutical cluster in Stavropol
23 January 2024
A pharmaceutical cluster is being planned for the Stavropol Territory, with the aim of attracting funding from international partners. It is anticipated that India will take an interest in the collaboration, and the regional government is actively pursuing this opportunity. However, negotiations with potential partners have not yielded outcomes, as revealed during a press conference featuring the regional governor, Vladimir Vladimirov.
665 million rubles will be invested to create a medical device production in Pskov region
22 January 2024
On the territory of the Moglino special economic zone (SEZ) in the Pskov region, an enterprise will appear for the production of medical products, in particular, surgical endoscopic staplers and catheters for hemodialysis. The supervisory board of the SEZ has approved the investment project, with a planned investment of 665 million rubles, as reported by the regional government’s press service.
Moscow technopolis residents invested 160 billion rubles to the city’s economy
22 January 2024
The volume of investments of companies operating in the special economic zone (SEZ) technopolis “Moscow” in the city’s economy over 18 years has exceeded 160 billion rubles, said the mayor of the capital Sergei Sobyanin.
19 January 2024
An open science competition held by a Canadian nonprofit has announced the discovery of molecules that could someday lead to new treatments for Parkinson’s disease.
MHRA approves ‘safer’ medicine alternative for rare disease
19 January 2024
A new drug has been approved in the UK as a safer alternative to corticosteroids to treat Duchenne muscular dystrophy (DMD).
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024